Introducing Less Invasive Ventricular Enhancement (LIVE®)

  • Remodel Heart Failure
  • Regain Function
  • Renew Life

About Us

BioVentrix, Inc. is a privately held medical device company headquartered in Mansfield, MA, USA, focused on the development of less invasive therapies to treat the failing left ventricle, the most common cause of heart failure. BioVentrix technologies aim to improve cardiac function by directly addressing left ventricular dilation.

Less Invasive Ventricular Enhancement or LIVE® is a revolutionary procedure which offers a new treatment option for patients suffering from ischemic cardiomyopathy. The Revivent TC® TransCatheter Ventricular Enhancement System is a safer and less invasive alternative to surgical ventricular remodeling. It was developed for the purpose of excluding discrete left ventricular scar, thereby reconfiguring abnormal cardiac geometry that leads to dysfunction. Our unique system provides a new solution for multidisciplinary heart teams and their patients by its proven clinical improvements.

Our Management Team

Our Board of Directors

  • David Richmond – Founding Partner and Chairman, Richmond Brothers, Inc.
  • Mike Taglich – Taglich Brothers Investment Banking